Tag: gsk

GlaxoSmithKline Pharmaceuticals is re-entering India’s oncology market with the launch of Jemperli (dostarlimab) and Zejula (niraparib)— precision therapies indicated in the treatment of certain gynaecological cancers.GSK had exited the ...

GSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late-stage ...

By Diana Novak JonesLondon: U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in ...

GSK on Wednesday said it had reached a confidential settlement on a litigation in California alleging that the British drugmaker's discontinued heartburn drug Zantac caused cancer.The trial for the ...

GlaxoSmithKline Pharmaceuticals (GSK India) on Wednesday reported 13% year-on-year (YoY) jump of net profit to Rs 131 crore for the quarter ended June 2023 led by robust volumes, price ...